Valeant Pharma Buys Aton Pharma
Valeant Pharmaceuticals International (NYSE: VRX) has completed its $318 million acquisition of Aton Pharma Inc., a Lawrenceville, N.J.-based drug company focused on ophthalmology and certain orphan indications. Aton Pharma had raised over $37 million in VC funding from firms like Aisling Capital, HealthCare Ventures, Johnson & Johnson Development Corporation.
27 May 2010•1 min read
